FDA Purple Book · Reference family
tenecteplase (TNKase)
tenecteplase is an FDA-licensed reference biologic from Genentech, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2025
Reference approved
Reference product
351(a)BLA 103909
TNKase tenecteplase
Genentech, Inc.
- Approved
- Feb 28, 2025
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for tenecteplase, in chronological order.
Reference approval
Approval date of the reference tenecteplase product.
1 yr 3 mo ago
Frequently asked questions
Are there biosimilars approved for tenecteplase (TNKase)?
No 351(k) biosimilars or interchangeable biosimilars referencing tenecteplase are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.